Anti-ORF26 [ORF26]

This monoclonal antibody for KSHV ORF26 (capsid) has been developed using ORF26 protein as an antigen and has demonstrated broad applicability in helping to discern distinct subpopulations of KSHV associated viral particles at various stages of virion assembly.

Contributors

Inventor Institute
Fanxiu Zhu Florida State University Research Foundation
SKU: 160640
Product description: Kaposi’s sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi’s sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015). ORF26 (capsid) is a gene associated with the late lytic viral life cycle of KSHV. This monoclonal antibody for KSHV ORF26 (capsid) has been developed using ORF26 protein as an antigen and has demonstrated broad applicability in helping to discern distinct subpopulations of KSHV associated viral particles at various stages of virion assembly.
Conjugation: Unconjugated
Isotype: IgG
Immunogen: ORF26 protein
Cat. #: 160640
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Genetics; Microbiology
Application: WB
Target: Open Reading Frame 26
Reactivity: Other Species
Host: Mouse
Class: Monoclonal
Target background: Kaposi’s sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi’s sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015).ORF26 (capsid) is a gene associated with the late lytic viral life cycle of KSHV. This monoclonal antibody for KSHV ORF26 (capsid) has been developed using ORF26 protein as an antigen and has demonstrated broad applicability in helping to discern distinct subpopulations of KSHV associated viral particles at various stages of virion assembly.
Format: Liquid
Shipping conditions: Dry ice
References:

Fu et al. 2015. J Virol. 89(1):195-207. PMID: 25320298.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.